Trial of C134 in Patients With Recurrent GBM (C134-HSV-1)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03657576 |
|
Recruitment Status :
Active, not recruiting
First Posted : September 5, 2018
Last Update Posted : October 19, 2020
|
Sponsor:
University of Alabama at Birmingham
Collaborators:
Gateway for Cancer Research
National Cancer Institute (NCI)
Information provided by (Responsible Party):
James Markert, MD, University of Alabama at Birmingham
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Estimated Primary Completion Date : | September 2022 |
| Estimated Study Completion Date : | September 2024 |